Molecular epidemiological characterization of hypervirulent carbapenem-resistant Klebsiella pneumoniae in a hospital in Henan Province from 2020 to 2022.
10.3760/cma.j.cn112150-20230320-00204
- Author:
Xin Wei LIU
1
;
Deng Zhou LI
2
;
Yue HU
1
;
Rui ZHU
1
;
Dong Mei LIU
1
;
Meng Yu GUO
2
;
Yan Ying REN
2
;
Yi Fan LI
2
;
Yong Wei LI
3
Author Information
1. Department of Laboratory Medicine, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan Provincial Engineering and Technology Research Center for Characterization of Clinical Pathogenic Microbes, The Key Laboratory of Pathogenic Microbes & Antimicrobial Resistance Surveillance of Zhengzhou, Zhengzhou 450002, China.
2. The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450046, China.
3. Department of Laboratory Medicine, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan Provincial Engineering and Technology Research Center for Characterization of Clinical Pathogenic Microbes, The Key Laboratory of Pathogenic Microbes & Antimicrobial Resistance Surveillance of Zhengzhou, Zhengzhou 450002, China The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450046, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Klebsiella pneumoniae/genetics*;
Multilocus Sequence Typing;
Retrospective Studies;
Klebsiella Infections/drug therapy*;
Anti-Bacterial Agents/therapeutic use*;
Hospitals;
Carbapenem-Resistant Enterobacteriaceae/genetics*;
Microbial Sensitivity Tests;
Carbapenems/pharmacology*
- From:
Chinese Journal of Preventive Medicine
2023;57(8):1222-1230
- CountryChina
- Language:Chinese
-
Abstract:
Objective: The study investigated the clinical distribution, antimicrobial resistance and epidemiologic characteristics of hypervirulent Carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) in a hospital in Henan Province to provide a scientific basis for antibiotic use and nosocomial infection prevention and control. Methods: A retrospective analysis of the clinical data from the cases was carried out in this study. Clinical data of patients infected with the CRKP strain isolated from the clinical microbiology laboratory of Henan Provincial Hospital of Traditional Chinese Medicine from January 2020 to December 2022 were retrospectively analyzed. A string test, virulence gene screening, serum killing, and a G. mellonella infection model were used to screen hv-CRKP isolates. The clinical characteristics of hv-CRKP and the drug resistance rate of hv-CRKP to twenty-five antibiotics were analyzed using WHONET 5.6. Carbapenemase phenotypic characterization of the hv-CRKP was performed by colloidal gold immunochromatographic assay, and Carbapenemase genotyping, multi-locus sequence typing (MLST) and capsular serotyping of hv-CRKP isolates were performed by PCR and Sanger sequencing. Results: A total of non-duplicate 264 CRKP clinical isolates were detected in the hospital from 2020 to 2022, and 23 hv-CRKP isolates were detected, so the corresponding detection rate of hv-CRKP was 8.71% (23/264). The hv-CRKP isolates in this study were mainly from the intensive care unit (10/23) and neurosurgery department (8/23), and the main sources of hv-CRKP isolates were sputum (10/23) and bronchoalveolar lavage fluid (6/23). The hv-CRKP isolates in this study were highly resistant to β-lactam antibiotics, fluoroquinolones and aminoglycosides, and were only susceptible to colistin, tigecycline and ceftazidime/avibactam. The detection rate of the blaKPC-2 among 23 hv-CRKP isolates was 91.30% (21/23) and none of the class B and class D carbapenemases were detected. Results of MLST and capsular serotypes showed that ST11 type hv-CRKP was the dominant strain in the hospital, accounting for 56.52% (13/23), and K64 (9/13) and KL47 (4/13) were the major capsular serotypes. Conclusion: The hv-CRKP isolates from the hospital are mainly from lower respiratory tract specimens from patients admitted to the intensive care department and the drug resistance is relatively severe. The predominant strains with certain polymorphisms are mainly composed of the KPC-2-producing ST11-K64 and ST11-KL47 hv-CRKP isolates in the hospital.
